Cargando…
A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
For the initial phase of pandemic of coronavirus disease 2019 (COVID-19), repurposing drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been attempted with overlooked or overestimated efficacy owing to limited clinical evidence. Most early clinical trials...
Autores principales: | Chen, Po-Lin, Lee, Nan-Yao, Cia, Cong-Tat, Ko, Wen-Chien, Hsueh, Po-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751753/ https://www.ncbi.nlm.nih.gov/pubmed/33364959 http://dx.doi.org/10.3389/fphar.2020.584956 |
Ejemplares similares
-
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
por: Lee, Nan-Yao, et al.
Publicado: (2019) -
Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs
por: Rosa, Arianna Carolina, et al.
Publicado: (2020) -
In vitro diagnostics of coronavirus disease 2019: Technologies and application
por: Lai, Chih-Cheng, et al.
Publicado: (2021) -
Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment
por: Jain, Harsha, et al.
Publicado: (2021) -
Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
por: Bucolo, Claudio, et al.
Publicado: (2022)